HealthStream Dirección

Dirección controles de criterios 4/4

El CEO de HealthStream es Bobby Frist , nombrado en Jan 1990, tiene una permanencia de 34.83 años. compensación anual total es $727.11K, compuesta por 52.3% salario y 47.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 17.92% de las acciones de la empresa, por valor de €170.59M. La antigüedad media del equipo directivo y de la junta directiva es de 7.3 años y 23.8 años, respectivamente.

Información clave

Bobby Frist

Chief Executive Officer (CEO)

US$727.1k

Compensación total

Porcentaje del salario del CEO	52.3%
Permanencia del CEO	34.8yrs
Participación del CEO	17.9%
Permanencia media de la dirección	7.3yrs
Promedio de permanencia en la Junta Directiva	23.8yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Bobby Frist en comparación con los beneficios de HealthStream?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	US$20m
Jun 30 2024	n/a	n/a	US$18m
Mar 31 2024	n/a	n/a	US$18m
Dec 31 2023	US$727k	US$380k	US$15m
Sep 30 2023	n/a	n/a	US$13m
Jun 30 2023	n/a	n/a	US$13m
Mar 31 2023	n/a	n/a	US$12m
Dec 31 2022	US$750k	US$375k	US$12m
Sep 30 2022	n/a	n/a	US$9m
Jun 30 2022	n/a	n/a	US$7m
Mar 31 2022	n/a	n/a	US$6m
Dec 31 2021	US$642k	US$358k	US$6m
Sep 30 2021	n/a	n/a	US$7m
Jun 30 2021	n/a	n/a	US$8m
Mar 31 2021	n/a	n/a	US$9m
Dec 31 2020	US$577k	US$345k	US$14m
Sep 30 2020	n/a	n/a	US$17m
Jun 30 2020	n/a	n/a	US$18m
Mar 31 2020	n/a	n/a	US$17m
Dec 31 2019	US$617k	US$342k	US$14m
Sep 30 2019	n/a	n/a	US$14m
Jun 30 2019	n/a	n/a	US$13m
Mar 31 2019	n/a	n/a	US$14m
Dec 31 2018	US$602k	US$331k	US$13m
Sep 30 2018	n/a	n/a	US$13m
Jun 30 2018	n/a	n/a	US$12m
Mar 31 2018	n/a	n/a	US$11m
Dec 31 2017	US$533k	US$319k	US$9m

Compensación vs. Mercado: La compensación total de Bobby($USD727.11K) está por debajo de la media de empresas de tamaño similar en el mercado German ($USD1.48M).

Compensación vs. Ingresos: La compensación de Bobby ha sido consistente con los resultados de la empresa en el último año.

CEO

Bobby Frist (57 yo)

34.8yrs

Permanencia

US$727,109

Compensación

Mr. Robert A. Frist, Jr., also known as Bobby, is a Co-founder of Healthstream, Inc. and has been its Chief Executive Officer and Director since 1990. He serves as Member of Advisory Board at PsychHub, LLC...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Robert Frist	Co-Founder	34.8yrs	US$727.11k	17.92% € 170.6m
Scott Roberts	CFO & Senior VP	5.8yrs	US$685.90k	0.076% € 725.2k
Michael Sousa	Executive Vice President of Enterprise Applications	no data	US$955.83k	0.18% € 1.7m
Michael Collier	Executive Vice President of Corporate Strategy & Development	no data	US$834.25k	0.13% € 1.3m
Trisha Coady	Senior Vice President of Workforce Development Solutions	6yrs	US$706.01k	0.077% € 737.5k
Jeffrey Cunningham	Senior VP & CTO	7.3yrs	US$482.35k	0.085% € 813.3k
Mollie Condra	Vice President of Investor Relations & Communications	no data	sin datos	sin datos
Sneha Oakley	VP, Compliance Officer & General Counsel	no data	sin datos	sin datos
Scott Fenstermacher	Senior Vice President of Sales	7.3yrs	sin datos	0.041% € 390.5k
Kevin O'Hara	Senior Vice President of Platform Solutions	no data	US$695.90k	0.034% € 320.2k
Michael McQuigg	Senior Vice President of Digital & Network Development	5.8yrs	sin datos	0.071% € 674.9k
Arthur Newman	Senior Executive Advisor	no data	US$429.29k	sin datos

7.3yrs

Permanencia media

55yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de HL5 es experimentado (7.3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Robert Frist	Co-Founder	34.8yrs	US$727.11k	17.92% € 170.6m
Thompson Dent	Lead Independent Director	29.8yrs	US$118.01k	0.44% € 4.2m
Terry Rappuhn	Independent Director	2.8yrs	US$117.50k	0.012% € 118.3k
Jeffrey McLaren	Independent Director	34.8yrs	US$110.51k	0.064% € 604.6k
William Stead	Independent Director	26.8yrs	US$113.01k	0.14% € 1.3m
Linda Rebrovick	Independent Director	23.8yrs	US$111.60k	0.18% € 1.7m
Frank Gordon	Independent Director	22.8yrs	US$112.51k	0.75% € 7.1m
Deborah Tate	Independent Director	14.8yrs	US$110.51k	0.070% € 670.6k
Alex Jahangir	Independent Director	1.4yrs	US$102.65k	0.0037% € 35.2k

23.8yrs

Permanencia media

67yo

Promedio de edad

Junta con experiencia: Los miembros de la junta directiva de HL5 son experimentados ( 23.8 años antigüedad media).

HealthStream Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

HealthStream, Inc., Annual General Meeting, May 30, 2024

Insider recently sold €170k worth of stock

HealthStream Announces the Addition of Dr. Alex Jahangir to the Board of Directors

HealthStream, Inc. Approves the Retirement of Michael D. Shmerling as Director

President & COO recently sold €343k worth of stock

Independent Director recently sold €81k worth of stock

Recent updates

HealthStream, Inc. (NasdaqGS:HSTM) acquired Substantially All Assets of Total Clinical Placement System and The Clinical Hub, Inc. from Cyber Healthcare Solutions, LLC for $2.25 million.

HealthStream, Inc. Revises Earnings Guidance for the Full Year 2024

HealthStream, Inc. to Report Q3, 2024 Results on Oct 21, 2024

Second quarter 2024 earnings released: EPS: US$0.14 (vs US$0.14 in 2Q 2023)

Healthstream, Inc. Approves Quarterly Cash Dividend, Payable on August 16, 2024

HealthStream, Inc. to Report Q2, 2024 Results on Jul 22, 2024

Now 21% undervalued

First quarter 2024 earnings released: EPS: US$0.17 (vs US$0.086 in 1Q 2023)

HealthStream, Inc. Reaffirms Earnings Guidance for 2024

HealthStream, Inc. to Report Q1, 2024 Results on Apr 22, 2024

HealthStream, Inc., Annual General Meeting, May 30, 2024

Upcoming dividend of US$0.028 per share

Insider recently sold €170k worth of stock

Full year 2023 earnings released: EPS: US$0.50 (vs US$0.40 in FY 2022)

HealthStream, Inc. Announces Increases Quarterly Dividend, Payable on March 22, 2024

HealthStream, Inc. to Report Q4, 2023 Results on Feb 19, 2024

Now 23% undervalued

Upcoming dividend of US$0.025 per share at 0.4% yield

Now 24% undervalued

HealthStream, Inc. Updates Earnings Guidance for the Year 2023

Third quarter 2023 earnings released: EPS: US$0.13 (vs US$0.12 in 3Q 2022)

HealthStream, Inc. to Report Q3, 2023 Results on Oct 23, 2023

HealthStream, Inc. (NasdaqGS:HSTM) announces an Equity Buyback for $10 million worth of its shares.

Second quarter 2023 earnings released: EPS: US$0.14 (vs US$0.10 in 2Q 2022)

Healthstream, Inc. Provides Revenue Guidance for the Year 2023

HealthStream Announces the Addition of Dr. Alex Jahangir to the Board of Directors

Upcoming dividend of US$0.025 per share at 0.4% yield

HealthStream, Inc. Approves the Retirement of Michael D. Shmerling as Director

President & COO recently sold €343k worth of stock

First quarter 2023 earnings released: EPS: US$0.086 (vs US$0.093 in 1Q 2022)

Upcoming dividend of US$0.025 per share at 0.4% yield

Independent Director recently sold €81k worth of stock

Full year 2022 earnings released: EPS: US$0.40 (vs US$0.18 in FY 2021)

HealthStream, Inc. to Report Q4, 2022 Results on Feb 20, 2023

HealthStream, Inc. (NasdaqGS:HSTM) acquired substantially all of the assets from Electronic Education Documentation System, LLC for $7 million.

HealthStream, Inc. (NasdaqGS:HSTM) acquired substantially all of the assets from Electronic Education Documentation System, LLC for $7 million.

Insufficient new directors

Third quarter 2022 earnings released: EPS: US$0.12 (vs US$0.048 in 3Q 2021)

HealthStream, Inc. to Report Q3, 2022 Results on Oct 24, 2022

Independent Director recently sold €118k worth of stock

Healthstream, Inc. Provides Earnings Guidance for the Year 2022

Second quarter 2022 earnings released: EPS: US$0.10 (vs US$0.077 in 2Q 2021)

HealthStream, Inc. to Report Q2, 2022 Results on Jul 25, 2022

HealthStream, Inc. (NasdaqGS:HSTM) acquired the remaining 80% stake in CloudCME, LLC for $8.1 million.

First quarter 2022 earnings released: EPS: US$0.093 (vs US$0.073 in 1Q 2021)

Insufficient new directors

HealthStream, Inc. Reiterates Earnings Guidance for the Fiscal Year 2022

HealthStream, Inc. to Report Q1, 2022 Results on Apr 25, 2022

HealthStream, Inc., Annual General Meeting, May 26, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

HealthStream, Inc. Provides Earnings Guidance for the Full Year 2022

HealthStream, Inc. to Report Q4, 2021 Results on Feb 21, 2022

HealthStream, Inc. (NasdaqGS:HSTM) acquired Substantially All Assets of Rievent Technologies for $4 million.

HealthStream, Inc. (NasdaqGS:HSTM) announces an Equity Buyback for $20 million worth of its shares.

Independent Director recently bought €88k worth of stock

Third quarter 2021 earnings released: EPS US$0.048 (vs US$0.082 in 3Q 2020)

Second quarter 2021 earnings released: EPS US$0.077 (vs US$0.11 in 2Q 2020)

Chairman recently bought €186k worth of stock

First quarter 2021 earnings released: EPS US$0.073 (vs US$0.22 in 1Q 2020)

HealthStream, Inc.Provides Earnings Guidance for the Year 2021

Independent Director recently sold €78k worth of stock

Independent Director has left the company

C. Martin Harris, M.D. Notifies HealthStream, Inc. His Decision to Resign as Member of its Board of Directors

Full year 2020 earnings released: EPS US$0.44 (vs US$0.44 in FY 2019)

Revenue beats expectations

HealthStream, Inc. to Report Q4, 2020 Results on Feb 23, 2021

HealthStream, Inc.(NasdaqGS:HSTM) dropped from Russell 2000 Growth-Defensive Index

HealthStream, Inc. (NasdaqGS:HSTM) acquired ProcessDATA, Ltd. for approximately $2 million.

HealthStream, Inc. (NasdaqGS:HSTM) acquired substantially all assets of myClinicalExchange LLC for $4.5 million.